Riskpilot← Back to searchSign inGet full accessBudolfi Privathospital I/S
I/SActiveCVR 41755547Vandmanden 10EHospital activities · NACE 8610Est. 202087 employeesbudolfiprivathospital.dk
Revenue 2024
DKK 13,7M
+7% vs 2023
EBITDA margin
-44.3%
-4% vs 2023
Equity ratio
-12.5%
Financial strength
Net profit 2024
DKK -7,4M
-22% vs 2023
| Revenue | DKK 13,7M | +7% |
| EBITDA | DKK -6,1M | -4% |
| Net profit | DKK -7,4M | -22% |
| Total assets | DKK 35,5M | +387% |
| Equity | DKK -4,5M | +39% |
| Employees | 87 | — |
Legal name
Budolfi Privathospital I/S
CVR number
41755547
Legal form
Interessentskab
NACE code
8610 · Hospital activities
Founded
12. oktober 2020
Share capital
—
Employees
87 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af interessenterne i forening
Company purpose
Interessentskabets formål er at drive privathospital
Address
Vandmanden 10E
Phone
+4570111166
Email
info@budolfiprivathospital.dk
Website
budolfiprivathospital.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 5.311 | 6.436 | 12.840 | 13.748 |
| Staff expenses | -2.254 | -8.584 | -18.697 | -19.833 |
| EBITDA | 3.057 | -2.148 | -5.857 | -6.085 |
| Depreciation & amort. | -4 | -12 | -132 | -968 |
| EBIT | 3.053 | -2.160 | -5.989 | -7.053 |
| Net financials | -53 | 73 | -119 | -394 |
| Profit before tax | 3.000 | -2.086 | -6.107 | -7.447 |
| Tax | -0 | -0 | -0 | -0 |
| Net profit | 3.000 | -2.086 | -6.107 | -7.447 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 5.424 | 6.905 | 7.289 | 35.510 |
| Equity | 3.108 | 1.021 | -7.281 | -4.452 |
| Long-term debt | 0 | 0 | 3.740 | 23.611 |
| Short-term debt | 2.316 | 5.883 | 10.830 | 16.351 |
| Total debt | 2.316 | 5.883 | 14.569 | 39.962 |
EBITDA margin
-44.3%
This company
15.8%
Market median
-380% vs market
20212024
Equity ratio
-12.5%
This company
38.2%
Market median
-133% vs market
20212024
Return on equity
-744704300.0%
This company
18.4%
Market median
-4047306078% vs market
20212024
Net profit margin
-54.2%
This company
8.1%
Market median
-769% vs market
20212024
Asset turnover
0.39×
This company
1.12×
Market median
-65% vs market
20212024
Debt / equity
8.98×
This company
0.62×
Market median
-1348% vs market
20212024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JM Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (2) | ||
MA Stakeholder | Stakeholder | 2020 – 2020 |
JB Stakeholder | Stakeholder | 2020 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2024 | |
| Former (1) | ||
| Chairman | 2023 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Budolfi Privathospital I/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jacob Madsen | Chief Executive Officer | 0 companies |
| Mikkel Attermann Bruhn | Stakeholder | 0 companies |
| Janus Bo Bechmann Jespersen | Stakeholder | 0 companies |
| Peder Christian Frandsen | Chairman | 0 companies |
| Jakob Stegger | Chairman | 0 companies |